Bioceres Crop Solutions Q3 2024 GAAP EPS $0.15 Misses $0.16 Estimate, Sales $84.000M Miss $98.500M Estimate
Bioceres Crop Solutions Q3 2024 GAAP EPS $0.15 Misses $0.16 Estimate, Sales $84.000M Miss $98.500M Estimate
Bioceres Crop Solutions 2024年第三季度GAAP每股收益0.15美元未達到0.16美元的預期，8,4000萬美元的銷售額低於9,85億美元的預期
Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly earnings of $0.15 per share which missed the analyst consensus estimate of $0.16 by 6.25 percent. This is a 65.12 percent decrease over earnings of $0.43 per share from the same period last year. The company reported quarterly sales of $84.000 million which missed the analyst consensus estimate of $98.500 million by 14.72 percent. This is a 10.26 percent decrease over sales of $93.605 million the same period last year.
Bioceres Crop Solutions（納斯達克股票代碼：BIOX）公佈的季度每股收益爲0.15美元，比分析師共識預期的0.16美元低6.25％。與去年同期的每股收益0.43美元相比，下降了65.12％。該公司公佈的季度銷售額爲84000萬美元，比分析師普遍預期的985億美元低14.72％。這比去年同期的9,360.5萬美元的銷售額下降了10.26％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。